General Information of the Protein
Protein ID |
PT01195
|
||||
---|---|---|---|---|---|
Protein Name |
D(1A) dopamine receptor
|
||||
Secondarily Protein Name |
Dopamine D1 receptor
|
||||
Gene Name |
DRD1
|
||||
Sequence |
MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Membrane receptor
>
Family A G protein-coupled receptor
>
Small molecule receptor (family A GPCR)
>
Monoamine receptor
>
Dopamine receptor
|
||||
Function |
Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
HGNC ID | |||||
Subcellular Location |
Cell membrane
Endoplasmic reticulum membrane
Cell projection
Cilium membrane
Cell projection
Dendrite
Cell projection
Dendritic spine
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000053 , COS-7
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000026 , CHO-K1
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000041 , LTK-
Cell Line ID: CL000074 , SK-N-MC
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Dopamine D1 receptor (D1R) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 8 Target-related Diseases | 8 | |||
1 | Hypertension [ICD-11: BA00-BA04] | ||||
2 | Spontaneous abortion [ICD-11: JA00.0] | ||||
3 | Parkinson disease [ICD-11: 8A00.0] | ||||
4 | Allergy [ICD-11: 4A80-4A85] | ||||
5 | Cocaine addiction [ICD-11: 6C45.2] | ||||
6 | Schizophrenia [ICD-11: 6A20] | ||||
7 | Pain [ICD-11: MG30-MG3Z] | ||||
8 | Type-2 diabetes [ICD-11: 5A11] | ||||
Approved Drug(s) | 4 Approved Drugs | 4 | |||
1 | Fenoldopam | Approved | |||
2 | Methylergonovine | Approved | |||
3 | Pergolide | Approved | |||
4 | Phenyltoloxamine | Approved | |||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | Ecopipam | Phase 3 | |||
2 | Zicronapine | Phase 3 | |||
Discontinued Drug(s) | 5 Discontinued Drugs | 5 | |||
1 | CY-208243 | Discontinued in Phase 2 | |||
2 | A 77636 | Terminated | |||
3 | A-68930 | Terminated | |||
4 | SKF 38393 | Terminated | |||
5 | SKF-81297 | Terminated |
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID | Protein Name | Protein Organism | |
PT04612 | D(1B) dopamine receptor | Rattus norvegicus, Rat | |
---|---|---|---|
PT07597 | D(1B) dopamine receptor | Mus musculus, Mouse |